CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 126 filers reported holding CYTOKINETICS INC in Q4 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $19,850,000 | +131.5% | 1,633,726 | +74.9% | 0.00% | +100.0% |
| Q3 2016 | $8,574,000 | +2.4% | 934,027 | +5.9% | 0.00% | 0.0% |
| Q2 2016 | $8,370,000 | +33.7% | 881,984 | -0.7% | 0.00% | +100.0% |
| Q1 2016 | $6,260,000 | -34.9% | 887,957 | -3.4% | 0.00% | -50.0% |
| Q4 2015 | $9,618,000 | +61.8% | 919,488 | +3.5% | 0.00% | 0.0% |
| Q3 2015 | $5,943,000 | -1.6% | 888,300 | -1.2% | 0.00% | +100.0% |
| Q2 2015 | $6,041,000 | -5.8% | 898,910 | -4.9% | 0.00% | -50.0% |
| Q1 2015 | $6,411,000 | -15.2% | 945,528 | +0.1% | 0.00% | 0.0% |
| Q4 2014 | $7,563,000 | +163.2% | 944,173 | +15.7% | 0.00% | +100.0% |
| Q3 2014 | $2,873,000 | -28.7% | 816,242 | -3.2% | 0.00% | 0.0% |
| Q2 2014 | $4,030,000 | -51.8% | 843,197 | -4.1% | 0.00% | -50.0% |
| Q1 2014 | $8,357,000 | +77.1% | 879,689 | +21.2% | 0.00% | +100.0% |
| Q4 2013 | $4,718,000 | -16.6% | 725,888 | -2.9% | 0.00% | -50.0% |
| Q3 2013 | $5,657,000 | – | 747,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,260,836 | $54,752,000 | 9.31% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 118,102 | $1,518,000 | 1.14% |
| FORTALEZA ASSET MANAGEMENT INC/ | 20,560 | $264,000 | 0.53% |
| TFS CAPITAL LLC | 95,987 | $1,233,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 152,200 | $1,956,000 | 0.38% |
| Nine Chapters Capital Management LLC | 20,600 | $265,000 | 0.36% |
| Timpani Capital Management LLC | 67,551 | $868,000 | 0.35% |
| WASATCH ADVISORS LP | 1,492,698 | $19,181,000 | 0.28% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $29,836,000 | 0.26% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 208,781 | $2,682,000 | 0.19% |